Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin for Adolescent Migraine Prevention
NCT03150797Phase 2Terminated
- Start
- Aug 2017
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of melatonin in migraine. Started Aug 2017; status: terminated.
02
Drugs
melatonin
03
Conditions
migraine
Beyond the preview
Go deeper on NCT03150797.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03150797.